Tom Clayton
Head of Data
MBA at ACU, MDSI at UTS
Tom holds a MBA from Australian Catholic University and Masters of Data Science and Innovation from University Technology Sydney.

From the Journal
It’s a living thing – investing in biologics
Adrian Cotiga explains the rationale behind Platinum's investment in biologics company Lonza.
From cheap trinkets to the DeepSeek moment
DeepSeek is another symbol of Asia’s capacity for change. But what does it mean for investors?
Notes on the end of a theme...
What happens when an investment theme comes to an end?
Europe: why President Trump's tough love is a catalyst for change
Europe is adapting to new geopolitical realities. Which companies could benefit from that change?
Subscribe to Platinum
Receive our expert investment insights and market updates.

Journal Articles
Read market leading insights.

Market Updates
Get market updates from our analysts

Quarterly Reports
Receive quarterly investment reports